Features of taxation of pharmaceutical enterprises in the countries of the European union

Abstract

The article presents the results of an analysis of international experience in the taxation of pharmaceutical companies in EU countries. It is determined that various tax approaches, adapted to national economic and social conditions, allow EU member states to effectively manage their tax systems, contributing to the development of a market economy and improving the quality of medical services.